申请人:UNIVERSITEIT ANTWERPEN
公开号:US20140357650A1
公开(公告)日:2014-12-04
The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.
本发明涉及具有高选择性和特异性的新型抑制剂,用于FAP(成纤维细胞激活蛋白)。所述抑制剂可用作人类和/或兽医药物,特别用于治疗和/或预防与FAP相关的疾病,如但不限于增殖性疾病。